Logo image of ABCM

ABCAM PLC-SPON ADR (ABCM) Stock Fundamental Analysis

NASDAQ:ABCM - Nasdaq - US0003802040 - ADR - Currency: USD

23.99  +0.01 (+0.04%)

After market: 23.99 0 (0%)

Fundamental Rating

5

Overall ABCM gets a fundamental rating of 5 out of 10. We evaluated ABCM against 562 industry peers in the Biotechnology industry. Both the profitability and the financial health of ABCM get a neutral evaluation. Nothing too spectacular is happening here. ABCM is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ABCM had positive earnings in the past year.
In the past year ABCM had a positive cash flow from operations.
ABCM Yearly Net Income VS EBIT VS OCF VS FCFABCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.64%, ABCM belongs to the top of the industry, outperforming 93.86% of the companies in the same industry.
Looking at the Return On Equity, with a value of 0.93%, ABCM belongs to the top of the industry, outperforming 93.86% of the companies in the same industry.
With an excellent Return On Invested Capital value of 1.98%, ABCM belongs to the best of the industry, outperforming 94.69% of the companies in the same industry.
ABCM had an Average Return On Invested Capital over the past 3 years of 6.00%. This is significantly below the industry average of 14.31%.
The 3 year average ROIC (6.00%) for ABCM is well above the current ROIC(1.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.64%
ROE 0.93%
ROIC 1.98%
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ABCM Yearly ROA, ROE, ROICABCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 5 10 15

1.3 Margins

The Profit Margin of ABCM (1.94%) is better than 94.86% of its industry peers.
In the last couple of years the Profit Margin of ABCM has declined.
ABCM has a better Operating Margin (8.70%) than 95.36% of its industry peers.
In the last couple of years the Operating Margin of ABCM has declined.
ABCM has a Gross Margin of 72.69%. This is amongst the best in the industry. ABCM outperforms 83.58% of its industry peers.
ABCM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.7%
PM (TTM) 1.94%
GM 72.69%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
ABCM Yearly Profit, Operating, Gross MarginsABCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABCM is destroying value.
The number of shares outstanding for ABCM has been increased compared to 1 year ago.
Compared to 1 year ago, ABCM has an improved debt to assets ratio.
ABCM Yearly Shares OutstandingABCM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M
ABCM Yearly Total Debt VS Total AssetsABCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

ABCM has an Altman-Z score of 8.64. This indicates that ABCM is financially healthy and has little risk of bankruptcy at the moment.
ABCM's Altman-Z score of 8.64 is amongst the best of the industry. ABCM outperforms 85.41% of its industry peers.
The Debt to FCF ratio of ABCM is 19.99, which is on the high side as it means it would take ABCM, 19.99 years of fcf income to pay off all of its debts.
ABCM has a Debt to FCF ratio of 19.99. This is amongst the best in the industry. ABCM outperforms 94.03% of its industry peers.
ABCM has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
ABCM has a Debt to Equity ratio of 0.30. This is in the lower half of the industry: ABCM underperforms 71.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 19.99
Altman-Z 8.64
ROIC/WACC0.22
WACC8.89%
ABCM Yearly LT Debt VS Equity VS FCFABCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M

2.3 Liquidity

ABCM has a Current Ratio of 1.26. This is a normal value and indicates that ABCM is financially healthy and should not expect problems in meeting its short term obligations.
ABCM has a worse Current ratio (1.26) than 86.73% of its industry peers.
A Quick Ratio of 0.98 indicates that ABCM may have some problems paying its short term obligations.
ABCM has a worse Quick ratio (0.98) than 88.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.98
ABCM Yearly Current Assets VS Current LiabilitesABCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 402.64% over the past year.
ABCM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.30% yearly.
ABCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.70%.
Measured over the past years, ABCM shows a quite strong growth in Revenue. The Revenue has been growing by 11.64% on average per year.
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%

3.2 Future

Based on estimates for the next years, ABCM will show a very strong growth in Earnings Per Share. The EPS will grow by 40.12% on average per year.
ABCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.28% yearly.
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ABCM Yearly Revenue VS EstimatesABCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
ABCM Yearly EPS VS EstimatesABCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 44.43, which means the current valuation is very expensive for ABCM.
Based on the Price/Earnings ratio, ABCM is valued cheaper than 94.69% of the companies in the same industry.
When comparing the Price/Earnings ratio of ABCM to the average of the S&P500 Index (24.85), we can say ABCM is valued expensively.
A Price/Forward Earnings ratio of 49.32 indicates a quite expensive valuation of ABCM.
94.53% of the companies in the same industry are more expensive than ABCM, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.89, ABCM is valued quite expensively.
Industry RankSector Rank
PE 44.43
Fwd PE 49.32
ABCM Price Earnings VS Forward Price EarningsABCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

94.20% of the companies in the same industry are more expensive than ABCM, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABCM indicates a rather cheap valuation: ABCM is cheaper than 93.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 374.67
EV/EBITDA 55.61
ABCM Per share dataABCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ABCM has a very decent profitability rating, which may justify a higher PE ratio.
ABCM's earnings are expected to grow with 52.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y68.04%
EPS Next 3Y52.49%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ABCM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABCAM PLC-SPON ADR

NASDAQ:ABCM (12/5/2023, 8:00:00 PM)

After market: 23.99 0 (0%)

23.99

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-12 2022-09-12/dmh
Earnings (Next)N/A N/A
Inst Owners1.79%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.49B
Analysts80
Price Target20.23 (-15.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 44.43
Fwd PE 49.32
P/S 12.3
P/FCF 374.67
P/OCF 79.64
P/B 5.92
P/tB 42.37
EV/EBITDA 55.61
EPS(TTM)0.54
EY2.25%
EPS(NY)0.49
Fwd EY2.03%
FCF(TTM)0.06
FCFY0.27%
OCF(TTM)0.3
OCFY1.26%
SpS1.95
BVpS4.05
TBVpS0.57
PEG (NY)0.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.64%
ROE 0.93%
ROCE 3.54%
ROIC 1.98%
ROICexc 2.23%
ROICexgc 7.95%
OM 8.7%
PM (TTM) 1.94%
GM 72.69%
FCFM 3.28%
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ROICexc(3y)7.76%
ROICexc(5y)11.54%
ROICexgc(3y)24.8%
ROICexgc(5y)47.7%
ROCE(3y)9.88%
ROCE(5y)14%
ROICexcg growth 3Y-57.08%
ROICexcg growth 5Y-37.19%
ROICexc growth 3Y-42.21%
ROICexc growth 5Y-23.94%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 19.99
Debt/EBITDA 2.79
Cap/Depr 90.64%
Cap/Sales 12.16%
Interest Coverage 9.53
Cash Conversion 69.81%
Profit Quality 169.12%
Current Ratio 1.26
Quick Ratio 0.98
Altman-Z 8.64
F-Score5
WACC8.89%
ROIC/WACC0.22
Cap/Depr(3y)181.11%
Cap/Depr(5y)191.67%
Cap/Sales(3y)16.16%
Cap/Sales(5y)14.67%
Profit Quality(3y)125.12%
Profit Quality(5y)105.69%
High Growth Momentum
Growth
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
EBIT growth 1Y-18.45%
EBIT growth 3Y-22.8%
EBIT growth 5Y-5.74%
EBIT Next Year197.84%
EBIT Next 3Y63.16%
EBIT Next 5Y39.34%
FCF growth 1Y-42.5%
FCF growth 3Y-17.2%
FCF growth 5Y-14.26%
OCF growth 1Y66.98%
OCF growth 3Y4.34%
OCF growth 5Y8.73%